SCHEMBL1848185

SCHEMBL1848185

[CH]1CCC2CCCC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4325388 0.90
SCHEMBL575142 0.83
SCHEMBL4312469 0.83
SCHEMBL4331396 0.79
SCHEMBL4321468 0.79
SCHEMBL477461 0.77
SCHEMBL25282504 0.76
SCHEMBL835264 0.76
SCHEMBL4219851 0.75
SCHEMBL17966606 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023110138-A1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2023-06-22 WO claimed
US-20180148449-A1 Substituted-Quinoxaline-Type Bridged-Piperidine Compounds and the Uses Thereof PURDUE PHARMA L.P. 2018-05-31 US claimed
US-20160009717-A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA L.P. 2016-01-14 US claimed
US-9145408-B2 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators PURDUE PHARMA L.P. (US) 2015-09-29 US claimed
EP-2324013-B3 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA LP (US) 2014-10-22 EP claimed
US-20130274265-A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA L.P. 2013-10-17 US claimed
EP-2324013-B1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA LP (US) 2012-09-19 EP claimed
US-20110178090-A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA L.P. 2011-07-21 US claimed
EP-2324013-A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF Purdue Pharma LP (US) 2011-05-25 EP claimed
WO-2010010458-A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA L.P. (US) 2010-01-28 WO claimed
EP-0330026-B1 Piperidinoalkyl derivatives of carboxylic acid amides TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1994-10-05 EP claimed
US-5025033-A Alkylene diamines TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-06-18 US claimed
US-4804665-A NERVOUS SYSTEM DISORDERS; COGNITION ACTIVATORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-02-14 US claimed
WO-2023110138-A1 INHIBITORS OF TRANSGLUTAMINASES ZEDIRA GMBH (DE) 2023-06-22 WO disclosed
US-11111246-B2 Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds PURDUE PHARMA L.P. (US) 2021-09-07 US disclosed
US-20200223847-A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF PURDUE PHARMA LP (US) 2020-07-16 US disclosed
EP-0330026-A1 Piperidinoalkyl derivatives of carboxylic acid amides Takeda Chemical Industries, Ltd. (JP) 1989-08-30 EP disclosed
EP-0326106-A2 Alkylene diamines Takeda Chemical Industries, Ltd. (JP) 1989-08-02 EP disclosed
US-4804665-A NERVOUS SYSTEM DISORDERS; COGNITION ACTIVATORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-02-14 US disclosed
EP-0273659-A1 Azaspiro compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1988-07-06 EP disclosed